Search research articles
Contact Us
Filters
Showing results (641-650 of 680) with videos related to
Page
of 68
Sort By:
The Lancet. Microbe
|
May 18, 2024
SARS-CoV-2 recombinant spike ferritin nanoparticle vaccine adjuvanted with Army Liposome Formulation containing monophosphoryl lipid A and QS-21: a phase 1, randomised, double-blind, placebo-controlled, first-in-human clinical trial
Brittany L Ober Shepherd, Paul T Scott, Jack N Hutter, et al.
Medrxiv : the Preprint Server for Health Sciences
|
December 16, 2022
Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 Protein Vaccine
Gustavo H Dayan, Nadine Rouphael, Stephen R Walsh, et al.
Plos Pathogens
|
December 8, 2020
RV144 HIV-1 vaccination impacts post-infection antibody responses
Thembi Mdluli, Ningbo Jian, Bonnie Slike, et al.
The Journal of Clinical Investigation
|
August 9, 2014
FCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trial
Shuying S Li, Peter B Gilbert, Georgia D Tomaras, et al.
Eclinicalmedicine
|
November 8, 2023
Efficacy of a monovalent (D614) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, multi-country study
Gustavo H Dayan, Nadine Rouphael, Stephen R Walsh, et al.
Plos Pathogens
|
March 2, 2021
Correction: RV144 HIV-1 vaccination impacts post-infection antibody responses
Thembi Mdluli, Ningbo Jian, Bonnie Slike, et al.
Nature Communications
|
May 25, 2026
Long-read deep sequencing reveals high rates of multilineage transmission and rapid viral population changes in acute HIV infection
James I Mullins, Wenjie Deng, Elena E Giorgi, et al.
Science Translational Medicine
|
September 20, 2019
Immune correlates of the Thai RV144 HIV vaccine regimen in South Africa
Glenda E Gray, Ying Huang, Nicole Grunenberg, et al.
The Lancet. HIV
|
June 15, 2018
Subtype C ALVAC-HIV and bivalent subtype C gp120/MF59 HIV-1 vaccine in low-risk, HIV-uninfected, South African adults: a phase 1/2 trial
Linda-Gail Bekker, Zoe Moodie, Nicole Grunenberg, et al.
Virus Evolution
|
September 17, 2021
RV144 vaccine imprinting constrained HIV-1 evolution following breakthrough infection
Eric Lewitus, Eric Sanders-Buell, Meera Bose, et al.
Page
of 68
Search research articles
Search
Showing results (641-650 of 680) with videos related to
Sort By:
Page
of 68
The Lancet. Microbe
|
May 18, 2024
SARS-CoV-2 recombinant spike ferritin nanoparticle vaccine adjuvanted with Army Liposome Formulation containing monophosphoryl lipid A and QS-21: a phase 1, randomised, double-blind, placebo-controlled, first-in-human clinical trial
Brittany L Ober Shepherd, Paul T Scott, Jack N Hutter, et al.
Medrxiv : the Preprint Server for Health Sciences
|
December 16, 2022
Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 Protein Vaccine
Gustavo H Dayan, Nadine Rouphael, Stephen R Walsh, et al.
Plos Pathogens
|
December 8, 2020
RV144 HIV-1 vaccination impacts post-infection antibody responses
Thembi Mdluli, Ningbo Jian, Bonnie Slike, et al.
The Journal of Clinical Investigation
|
August 9, 2014
FCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trial
Shuying S Li, Peter B Gilbert, Georgia D Tomaras, et al.
Eclinicalmedicine
|
November 8, 2023
Efficacy of a monovalent (D614) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, multi-country study
Gustavo H Dayan, Nadine Rouphael, Stephen R Walsh, et al.
Plos Pathogens
|
March 2, 2021
Correction: RV144 HIV-1 vaccination impacts post-infection antibody responses
Thembi Mdluli, Ningbo Jian, Bonnie Slike, et al.
Nature Communications
|
May 25, 2026
Long-read deep sequencing reveals high rates of multilineage transmission and rapid viral population changes in acute HIV infection
James I Mullins, Wenjie Deng, Elena E Giorgi, et al.
Science Translational Medicine
|
September 20, 2019
Immune correlates of the Thai RV144 HIV vaccine regimen in South Africa
Glenda E Gray, Ying Huang, Nicole Grunenberg, et al.
The Lancet. HIV
|
June 15, 2018
Subtype C ALVAC-HIV and bivalent subtype C gp120/MF59 HIV-1 vaccine in low-risk, HIV-uninfected, South African adults: a phase 1/2 trial
Linda-Gail Bekker, Zoe Moodie, Nicole Grunenberg, et al.
Virus Evolution
|
September 17, 2021
RV144 vaccine imprinting constrained HIV-1 evolution following breakthrough infection
Eric Lewitus, Eric Sanders-Buell, Meera Bose, et al.
Page
of 68